Anti-Aβ single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease
- 12 June 2006
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 23 (3), 502-511
- https://doi.org/10.1016/j.nbd.2006.04.012
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Amelioration of amyloid load by anti-Aβ single-chain antibody in Alzheimer mouse modelBiochemical and Biophysical Research Communications, 2006
- Efficient Neuronal Gene Transfer with AAV8 Leads to Neurotoxic Levels of Tau or Green Fluorescent ProteinsMolecular Therapy, 2006
- β-site specific intrabodies to decrease and prevent generation of Alzheimer's Aβ peptideThe Journal of cell biology, 2005
- Exacerbation of Cerebral Amyloid Angiopathy-Associated Microhemorrhage in Amyloid Precursor Protein Transgenic Mice by Immunotherapy Is Dependent on Antibody Recognition of Deposited Forms of Amyloid βJournal of Neuroscience, 2005
- Association of Aortic Atherosclerosis with Cerebral β-Amyloidosis and Learning Deficits in a Mouse Model of Alzheimer's DiseaseThe American Journal of Pathology, 2003
- Cerebral Hemorrhage After Passive Anti-Aβ ImmunotherapyScience, 2002
- Stability engineering of antibody single-chain Fv fragmentsJournal of Molecular Biology, 2001
- Mechanisms of Neuronal Degeneration in Alzheimer's DiseaseNeuron, 1996
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin NeuropeptidesScience, 1990